A multifunctional nanoparticle constructed with a detachable albumin outer shell and a redox-sensitive inner core for efficient siRNA delivery to hepatocellular carcinoma cells

References

• Siomi H, Siomi MC. On the road to reading the RNA-interference code. Nature. 2009;457:396–404.
   PubMed Web of Science ®Google Scholar
• Xia Y, Tian J, Chen X. Effect of surface properties on liposomal siRNA delivery. Biomaterials. 2016; 79:56–68.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim A, Miyata K, et al. Recent progress in development of siRNA delivery vehicles for cancer therapy. Adv Drug Deliv Rev. 2016; 104:61–77.
   PubMed Web of Science ®Google Scholar
• Tatiparti K, Sau S, Kashaw SK, et al. siRNA delivery strategies: a comprehensive review of recent developments. Nanomaterials (Basel). 2017;7:E77.
   PubMedGoogle Scholar
• Deng Y, Wang CC, Choy KW, et al. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene. 2014;538:217–227.
   PubMed Web of Science ®Google Scholar
• Park S, Jeong EJ, Lee J, et al. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery. Carbohydr Polym. 2013;92:57–62.
   PubMed Web of Science ®Google Scholar
• Yin T, Wang L, Yin L, et al. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer. Biomaterials. 2015;61:10–25.
   PubMed Web of Science ®Google Scholar
• Yin T, Liu J, Zhao Z, et al. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties. J Control Release. 2016;243:54–68.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhong Z, Zhuo R. Disulfide cross-linked polyethylenimines (PEI) prepared via thiolation of low molecular weight PEI as highly efficient gene vectors. Bioconjug Chem. 2008;19:499–506.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng M, Meng F, et al. Branched polyethylenimine derivatives with reductively cleavable periphery for safe and efficient in vitro gene transfer. Biomacromolecules. 2011;12:1032–1040.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Akita H, Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev. 2011; 63:152–160.
   PubMed Web of Science ®Google Scholar
• Fang Y, Xue J, Gao S. Cleavable PEGylation: a strategy for overcoming the “‘PEG dilemma’ in efficient drug delivery”. Drug Deliv. 2017;24:22–32.
   PubMed Web of Science ®Google Scholar
• Jiang L, Li L, He X, et al. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Biomaterials. 2015;52:126–139.
   PubMed Web of Science ®Google Scholar
• Anders CB, Chess JJ, Wingett DG, et al. Serum proteins enhance dispersion stability and influence the cytotoxicity and dosimetry of ZnO nanoparticles in suspension and adherent cancer cell models. Nanoscale Res Lett. 2015;10:448–470.
   PubMed Web of Science ®Google Scholar
• Xu Y, Jin X, Ping Q, et al. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. J Control Release. 2010;146:299–308.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhang S, Yang Q, et al. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials. 2013;34:8521–8530.
   PubMed Web of Science ®Google Scholar
• McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2011; 12:517–533.
   PubMed Web of Science ®Google Scholar
• Hawkins MJ, Soon-Shiong P, Desai N. Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev. 2008;60:876–885.
   PubMed Web of Science ®Google Scholar
• Tan YF, Mundargi RC, Chen MH, et al. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing. Small. 2014;10:1790–1798.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhang S, Ling Y, et al. pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery. J Control Release. 2015;220:529–544.
   PubMed Web of Science ®Google Scholar
• Dubey PK, Singodia D, Verma RK, et al. RGD modified albumin nanospheres for tumour vasculature targeting. J Pharm Pharmacol. 2011; 63:33–40.
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee JM, Oh KT, et al. Extremely small-sized globular poly(ethylene glycol)-cyclic RGD conjugates targeting integrin alphavbeta3 in tumor cells. Int J Pharm. 2017;528:1–7.
   PubMedGoogle Scholar
• Park K, Yang JA, Lee MY, et al. Reducible hyaluronic acid-siRNA conjugate for target specific gene silencing. Bioconjug Chem. 2013;24:1201–1209.
   PubMed Web of Science ®Google Scholar
• Habeeb AF. A sensitive method for localization of disulfide containing peptides in column effluents. Anal Biochem. 1973;56:60–65.
   PubMed Web of Science ®Google Scholar
• Nam JP, Nam K, Jung S, et al. Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy. J Control Release. 2015;209:179–185.
   PubMed Web of Science ®Google Scholar
• Chen Q, Wang X, Wang C, et al. Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy. ACS Nano. 2015;9:5223–5233.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ai G, Zhang C, et al. Novel linear peptides with high affinity to αvβ3 integrin for precise tumor identification. Theranostics. 2017;7:1511–1523.
   PubMed Web of Science ®Google Scholar
• Xie J, Chen K, Lee HY, et al. Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. J Am Chem Soc. 2008;130:7542–7543.
   PubMed Web of Science ®Google Scholar
• Danilov YN, Juliano RL. (Arg-Gly-Asp)n-albumin conjugates as a model substratum for integrin-mediated cell adhesion. Exp Cell Res. 1989;182:186–196.
   PubMed Web of Science ®Google Scholar
• Temming K, Lacombe M, Schaapveld RQ, et al. Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium. ChemMedChem. 2006;1:1200–1203.
   PubMed Web of Science ®Google Scholar
• Ryser HJ. A membrane effect of basic polymers dependent on molecular size. Nature. 1967;215:934–936.
   PubMed Web of Science ®Google Scholar
• Furumoto K, Yokoe J, Ogawara K, et al. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition. Int J Pharm. 2007;329:110–116.
   PubMed Web of Science ®Google Scholar
• Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev. 2003;55:199–215.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014;13:813–827.
   PubMed Web of Science ®Google Scholar
• Wang C, Chen B, Zou M, et al. Cyclic RGD-modified chitosan/graphene oxide polymers for drug delivery and cellular imaging. Colloids Surf B Biointerfaces. 2014;122:332–340.
   PubMed Web of Science ®Google Scholar